WuXi XDC Cash Offers Close With Offeror Gaining Majority Control

WuXi XDC Cayman, Inc. ( (HK:2268) ) just unveiled an update.

WuXi XDC Cayman Inc. and BioDlink International Company Limited announced the close of voluntary conditional cash offers for WuXi XDC shares and share options, which were made on behalf of the offeror by Citigroup Global Markets Asia. The offeror secured valid acceptances for about 61.47% of WuXi XDC’s issued share capital and approximately 99.74% of outstanding share options, resulting in majority control and the cancellation of most options, reshaping the company’s ownership and capital structure.

Following completion and subject to registration of transfers, the offeror and its concert parties now control roughly 61.47% of WuXi XDC’s voting rights, consolidating influence over corporate decisions. The offers were neither revised nor extended past the 31 March 2026 deadline, leaving only 20,000 share options outstanding and signaling a completed change of control that may affect minority shareholders’ position and future governance dynamics.

The most recent analyst rating on (HK:2268) stock is a Buy with a HK$82.00 price target. To see the full list of analyst forecasts on WuXi XDC Cayman, Inc. stock, see the HK:2268 Stock Forecast page.

More about WuXi XDC Cayman, Inc.

WuXi XDC Cayman Inc. is a Cayman Islands–incorporated company associated with the biopharmaceutical sector through its linkage with BioDlink International Company Limited, a Hong Kong–incorporated firm. The companies are listed in Hong Kong and are involved in equity and option-based shareholding structures that attract strategic investment activity.

Average Trading Volume: 4,511,532

Technical Sentiment Signal: Sell

Current Market Cap: HK$74.1B

See more data about 2268 stock on TipRanks’ Stock Analysis page.